• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Nanostructured Drug Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 148 Pages
  • Report Code: 24LS-21553
  • Formate :   
Download FREE Report Sample Download PDF File

United States Nanostructured Drug -MARKET ADVISORY SERVICES

Nanostructured Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nanostructured Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Nanostructured Drug market is segmented into
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension

Segment by Application, the Nanostructured Drug market is segmented into
Cancer and Tumors
Autoimmune Disorders

Regional and Country-level Analysis
The Nanostructured Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nanostructured Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Nanostructured Drug Market Share Analysis
Nanostructured Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nanostructured Drug business, the date to enter into the Nanostructured Drug market, Nanostructured Drug product introduction, recent developments, etc.
The major vendors covered:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
1 Study Coverage
1.1 Nanostructured Drug Product Introduction
1.2 Market Segments
1.3 Key Nanostructured Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nanostructured Drug Market Size Growth Rate by Type
1.4.2 Liposomes
1.4.3 Polymeric Micelles
1.4.4 Solid lipid Nanoparticles
1.4.5 Microemulsion and Nanoemulsion
1.4.6 Nanosuspension
1.5 Market by Application
1.5.1 Global Nanostructured Drug Market Size Growth Rate by Application
1.5.2 Cancer and Tumors
1.5.3 Autoimmune Disorders
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Nanostructured Drug Market Size, Estimates and Forecasts
2.1.1 Global Nanostructured Drug Revenue 2015-2026
2.1.2 Global Nanostructured Drug Sales 2015-2026
2.2 Global Nanostructured Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Nanostructured Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Nanostructured Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Nanostructured Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Nanostructured Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Nanostructured Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Nanostructured Drug Revenue Forecast by Region (2021-2026)

3 Global Nanostructured Drug Competitor Landscape by Players
3.1 Global Top Nanostructured Drug Sales by Manufacturers
3.1.1 Global Nanostructured Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Nanostructured Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Nanostructured Drug Manufacturers by Revenue
3.2.1 Global Nanostructured Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Nanostructured Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nanostructured Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nanostructured Drug Revenue in 2019
3.2.5 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nanostructured Drug Price by Manufacturers
3.4 Global Nanostructured Drug Manufacturing Base Distribution, Product Types
3.4.1 Nanostructured Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nanostructured Drug Product Type
3.4.3 Date of International Manufacturers Enter into Nanostructured Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Nanostructured Drug Market Size by Type (2015-2020)
4.1.1 Global Nanostructured Drug Sales by Type (2015-2020)
4.1.2 Global Nanostructured Drug Revenue by Type (2015-2020)
4.1.3 Nanostructured Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nanostructured Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Nanostructured Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Nanostructured Drug Revenue Forecast by Type (2021-2026)
4.2.3 Nanostructured Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nanostructured Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Nanostructured Drug Market Size by Application (2015-2020)
5.1.1 Global Nanostructured Drug Sales by Application (2015-2020)
5.1.2 Global Nanostructured Drug Revenue by Application (2015-2020)
5.1.3 Nanostructured Drug Price by Application (2015-2020)
5.2 Nanostructured Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Nanostructured Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Nanostructured Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Nanostructured Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Nanostructured Drug Market Size YoY Growth 2015-2026
6.1.1 United States Nanostructured Drug Sales YoY Growth 2015-2026
6.1.2 United States Nanostructured Drug Revenue YoY Growth 2015-2026
6.1.3 United States Nanostructured Drug Market Share in Global Market 2015-2026
6.2 United States Nanostructured Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Nanostructured Drug Players by Sales (2015-2020)
6.2.2 United States Top Nanostructured Drug Players by Revenue (2015-2020)
6.3 United States Nanostructured Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Nanostructured Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Nanostructured Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Nanostructured Drug Price by Type (2015-2020)
6.4 United States Nanostructured Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Nanostructured Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Nanostructured Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Nanostructured Drug Price Forecast by Type (2021-2026)
6.5 United States Nanostructured Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Nanostructured Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Nanostructured Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Nanostructured Drug Price by Application (2015-2020)
6.6 United States Nanostructured Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Nanostructured Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Nanostructured Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Nanostructured Drug Price Forecast by Application (2021-2026)

7 North America
7.1 North America Nanostructured Drug Market Size YoY Growth 2015-2026
7.2 North America Nanostructured Drug Market Facts & Figures by Country
7.2.1 North America Nanostructured Drug Sales by Country (2015-2020)
7.2.2 North America Nanostructured Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Nanostructured Drug Market Size YoY Growth 2015-2026
8.2 Europe Nanostructured Drug Market Facts & Figures by Country
8.2.1 Europe Nanostructured Drug Sales by Country
8.2.2 Europe Nanostructured Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Nanostructured Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Nanostructured Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Nanostructured Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Nanostructured Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Nanostructured Drug Market Size YoY Growth 2015-2026
10.2 Latin America Nanostructured Drug Market Facts & Figures by Country
10.2.1 Latin America Nanostructured Drug Sales by Country
10.2.2 Latin America Nanostructured Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Nanostructured Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Nanostructured Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Nanostructured Drug Sales by Country
11.2.2 Middle East and Africa Nanostructured Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Nanostructured Drug Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Nanostructured Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Nanostructured Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Description and Business Overview
12.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Nanostructured Drug Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Nanostructured Drug Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Description and Business Overview
12.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Nanostructured Drug Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Nanostructured Drug Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Description and Business Overview
12.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Nanostructured Drug Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Corporation Information
12.9.2 Astrazeneca Description and Business Overview
12.9.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astrazeneca Nanostructured Drug Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Description and Business Overview
12.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson & Johnson Nanostructured Drug Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck Nanostructured Drug Products Offered
12.11.5 Merck Recent Development
12.12 Novavax
12.12.1 Novavax Corporation Information
12.12.2 Novavax Description and Business Overview
12.12.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novavax Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Corporation Information
12.13.2 Stryker Description and Business Overview
12.13.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Stryker Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Corporation Information
12.14.2 Gilead Sciences Description and Business Overview
12.14.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Gilead Sciences Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Description and Business Overview
12.15.3 OSI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.15.4 OSI Pharmaceuticals Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Description and Business Overview
12.16.3 Kadmon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Kadmon Pharmaceuticals Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Corporation Information
12.17.2 Samyang Biopharm Description and Business Overview
12.17.3 Samyang Biopharm Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Samyang Biopharm Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Corporation Information
12.18.2 Mitsubishi Pharma Description and Business Overview
12.18.3 Mitsubishi Pharma Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mitsubishi Pharma Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Corporation Information
12.19.2 Kaken Pharmaceutical Description and Business Overview
12.19.3 Kaken Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Kaken Pharmaceutical Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Corporation Information
12.20.2 Selecta Biosciences Description and Business Overview
12.20.3 Selecta Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Selecta Biosciences Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Corporation Information
12.21.2 Par Pharmaceutical Description and Business Overview
12.21.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Par Pharmaceutical Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Corporation Information
12.22.2 Cerulean Pharma Description and Business Overview
12.22.3 Cerulean Pharma Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cerulean Pharma Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Description and Business Overview
12.23.3 Navidea Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Navidea Biopharmaceuticals Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Corporation Information
12.24.2 Lummy Description and Business Overview
12.24.3 Lummy Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Lummy Products Offered
12.24.5 Lummy Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nanostructured Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nanostructured Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Nanostructured Drug Market Segments

Table 2. Ranking of Global Top Nanostructured Drug Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Nanostructured Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Liposomes

Table 5. Major Manufacturers of Polymeric Micelles

Table 6. Major Manufacturers of Solid lipid Nanoparticles

Table 7. Major Manufacturers of Microemulsion and Nanoemulsion

Table 8. Major Manufacturers of Nanosuspension

Table 9. Global Nanostructured Drug Market Size Growth Rate by Application 2020-2026 (K MT)

Table 10. Global Nanostructured Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 11. Global Nanostructured Drug Sales by Regions 2015-2020 (K MT)

Table 12. Global Nanostructured Drug Sales Market Share by Regions (2015-2020)

Table 13. Global Nanostructured Drug Revenue by Regions 2015-2020 (US$ Million)

Table 14. Global Nanostructured Drug Sales Forecast by Region (2021-2026) (K MT)

Table 15. Global Nanostructured Drug Sales by Manufacturers (2015-2020) (K MT)

Table 16. Global Nanostructured Drug Sales Share by Manufacturers (2015-2020)

Table 17. Global Nanostructured Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 18. Global Nanostructured Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanostructured Drug as of 2019)

Table 19. Nanostructured Drug Revenue by Manufacturers (2015-2020) (US$ Million)

Table 20. Nanostructured Drug Revenue Share by Manufacturers (2015-2020)

Table 21. Key Manufacturers Nanostructured Drug Price (2015-2020) (USD/MT)

Table 22. Nanostructured Drug Manufacturers Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Nanostructured Drug Product Type

Table 24. Date of International Manufacturers Enter into Nanostructured Drug Market

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Global Nanostructured Drug Sales by Type (2015-2020) (K MT)

Table 27. Global Nanostructured Drug Sales Share by Type (2015-2020)

Table 28. Global Nanostructured Drug Revenue by Type (2015-2020) (US$ Million)

Table 29. Global Nanostructured Drug Revenue Share by Type (2015-2020)

Table 30. Nanostructured Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 31. Global Nanostructured Drug Sales Share by Type (2021-2026)

Table 32. Global Nanostructured Drug Sales by Application (2015-2020) (K MT)

Table 33. Global Nanostructured Drug Sales Share by Application (2015-2020)

Table 34. Global Nanostructured Drug Sales Share by Application (2021-2026)

Table 35. Global Nanostructured Drug Sales Market Share Forecast by Application (2021-2026)

Table 36. Global Nanostructured Drug Revenue by Application (2015-2020) (US$ Million)

Table 37. Global Nanostructured Drug Revenue Market Share Forecast by Application (2021-2026)

Table 38. United States Nanostructured Drug Sales (K MT) of Key Companies (2015-2020)

Table 39. United States Nanostructured Drug Sales Share by Company (2015-2020)

Table 40. United States Nanostructured Drug Revenue (US$ Million) by Company (2015-2020)

Table 41. United States Nanostructured Drug Sales (K MT) by Type (2015-2020)

Table 42. United States Nanostructured Drug Sales Share by Type (2015-2020)

Table 43. United States Nanostructured Drug Revenue (US$ Million) Market Share by Type (2015-2020)

Table 44. United States Nanostructured Drug Price (K MT) by Type (2015-2020)

Table 45. United States Nanostructured Drug Sales (K MT) by Type (2021-2026)

Table 46. United States Nanostructured Drug Sales Share by Type (2021-2026)

Table 47. United States Nanostructured Drug Revenue (US$ Million) Market Share by Type (2021-2026)

Table 48. United States Nanostructured Drug Revenue Share by Type (2021-2026)

Table 49. United States Nanostructured Drug Price (K MT) by Type (2021-2026)

Table 50. United States Nanostructured Drug Sales (K MT) by Application (2015-2020)

Table 51. United States Nanostructured Drug Sales Share by Application (2015-2020)

Table 52. United States Nanostructured Drug Revenue (US$ Million) Market Share by Application (2015-2020)

Table 53. United States Nanostructured Drug Sales (K MT) by Application (2021-2026)

Table 54. United States Nanostructured Drug Sales Share by Application (2021-2026)

Table 55. United States Nanostructured Drug Revenue (US$ Million) Market Share by Application (2021-2026)

Table 56. United States Nanostructured Drug Revenue Share by Application (2021-2026)

Table 57. North America Nanostructured Drug Sales by Country (2015-2020) (K MT)

Table 58. North America Nanostructured Drug Sales Market Share by Country (2015-2020)

Table 59. North America Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)

Table 60. North America Nanostructured Drug Revenue Market Share by Country (2015-2020)

Table 61. Europe Nanostructured Drug Sales by Country (2015-2020) (K MT)

Table 62. Europe Nanostructured Drug Sales Market Share by Country (2015-2020)

Table 63. Europe Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)

Table 64. Europe Nanostructured Drug Revenue Market Share by Country (2015-2020)

Table 65. Asia Pacific Nanostructured Drug Sales by Region (2015-2020) (K MT)

Table 66. Asia Pacific Nanostructured Drug Sales Market Share by Region (2015-2020)

Table 67. Asia Pacific Nanostructured Drug Revenue by Region (2015-2020) (US$ Million)

Table 68. Asia Pacific Nanostructured Drug Revenue Market Share by Region (2015-2020)

Table 69. Latin America Nanostructured Drug Sales by Country (2015-2020) (K MT)

Table 70. Latin America Nanostructured Drug Sales Market Share by Country (2015-2020)

Table 71. Latin Americaa Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)

Table 72. Latin America Nanostructured Drug Revenue Market Share by Country (2015-2020)

Table 73. Middle East and Africa Nanostructured Drug Sales by Country (2015-2020) (K MT)

Table 74. Middle East and Africa Nanostructured Drug Sales Market Share by Country (2015-2020)

Table 75. Middle East and Africa Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)

Table 76. Middle East and Africa Nanostructured Drug Revenue Market Share by Country (2015-2020)

Table 77. Merck Corporation Information

Table 78. Merck Description and Business Overview

Table 79. Merck Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 80. Merck Nanostructured Drug Product

Table 81. Merck Recent Development

Table 82. Pfizer Corporation Information

Table 83. Pfizer Description and Business Overview

Table 84. Pfizer Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 85. Pfizer Product

Table 86. Pfizer Recent Development

Table 87. Novartis Corporation Information

Table 88. Novartis Description and Business Overview

Table 89. Novartis Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 90. Novartis Product

Table 91. Novartis Recent Development

Table 92. Abbott Corporation Information

Table 93. Abbott Description and Business Overview

Table 94. Abbott Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 95. Abbott Product

Table 96. Abbott Recent Development

Table 97. GlaxoSmithKline Corporation Information

Table 98. GlaxoSmithKline Description and Business Overview

Table 99. GlaxoSmithKline Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 100. GlaxoSmithKline Product

Table 101. GlaxoSmithKline Recent Development

Table 102. Roche Corporation Information

Table 103. Roche Description and Business Overview

Table 104. Roche Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 105. Roche Product

Table 106. Roche Recent Development

Table 107. Sanofi Corporation Information

Table 108. Sanofi Description and Business Overview

Table 109. Sanofi Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 110. Sanofi Product

Table 111. Sanofi Recent Development

Table 112. Eli Lilly Corporation Information

Table 113. Eli Lilly Description and Business Overview

Table 114. Eli Lilly Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 115. Eli Lilly Product

Table 116. Eli Lilly Recent Development

Table 117. Astrazeneca Corporation Information

Table 118. Astrazeneca Description and Business Overview

Table 119. Astrazeneca Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 120. Astrazeneca Product

Table 121. Astrazeneca Recent Development

Table 122. Johnson & Johnson Corporation Information

Table 123. Johnson & Johnson Description and Business Overview

Table 124. Johnson & Johnson Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 125. Johnson & Johnson Product

Table 126. Johnson & Johnson Recent Development

Table 127. Celgene Corporation Information

Table 128. Celgene Description and Business Overview

Table 129. Celgene Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 130. Celgene Product

Table 131. Celgene Recent Development

Table 132. Novavax Corporation Information

Table 133. Novavax Description and Business Overview

Table 134. Novavax Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 135. Novavax Product

Table 136. Novavax Recent Development

Table 137. Stryker Corporation Information

Table 138. Stryker Description and Business Overview

Table 139. Stryker Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 140. Stryker Product

Table 141. Stryker Recent Development

Table 142. Gilead Sciences Corporation Information

Table 143. Gilead Sciences Description and Business Overview

Table 144. Gilead Sciences Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 145. Gilead Sciences Product

Table 146. Gilead Sciences Recent Development

Table 147. OSI Pharmaceuticals Corporation Information

Table 148. OSI Pharmaceuticals Description and Business Overview

Table 149. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 150. OSI Pharmaceuticals Product

Table 151. OSI Pharmaceuticals Recent Development

Table 152. Kadmon Pharmaceuticals Corporation Information

Table 153. Kadmon Pharmaceuticals Description and Business Overview

Table 154. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 155. Kadmon Pharmaceuticals Product

Table 156. Kadmon Pharmaceuticals Recent Development

Table 157. Samyang Biopharm Corporation Information

Table 158. Samyang Biopharm Description and Business Overview

Table 159. Samyang Biopharm Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 160. Samyang Biopharm Product

Table 161. Samyang Biopharm Recent Development

Table 162. Mitsubishi Pharma Corporation Information

Table 163. Mitsubishi Pharma Description and Business Overview

Table 164. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 165. Mitsubishi Pharma Product

Table 166. Mitsubishi Pharma Recent Development

Table 167. Kaken Pharmaceutical Corporation Information

Table 168. Kaken Pharmaceutical Description and Business Overview

Table 169. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 170. Kaken Pharmaceutical Product

Table 171. Kaken Pharmaceutical Recent Development

Table 172. Selecta Biosciences Corporation Information

Table 173. Selecta Biosciences Description and Business Overview

Table 174. Selecta Biosciences Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 175. Selecta Biosciences Product

Table 176. Selecta Biosciences Recent Development

Table 177. Par Pharmaceutical Corporation Information

Table 178. Par Pharmaceutical Description and Business Overview

Table 179. Par Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 180. Par Pharmaceutical Product

Table 181. Par Pharmaceutical Recent Development

Table 182. Cerulean Pharma Corporation Information

Table 183. Cerulean Pharma Description and Business Overview

Table 184. Cerulean Pharma Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 185. Cerulean Pharma Product

Table 186. Cerulean Pharma Recent Development

Table 187. Navidea Biopharmaceuticals Corporation Information

Table 188. Navidea Biopharmaceuticals Description and Business Overview

Table 189. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 190. Navidea Biopharmaceuticals Product

Table 191. Navidea Biopharmaceuticals Recent Development

Table 192. Lummy Corporation Information

Table 193. Lummy Description and Business Overview

Table 194. Lummy Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 195. Lummy Product

Table 196. Lummy Recent Development

Table 197. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 198. Key Challenges

Table 199. Market Risks

Table 200. Main Points Interviewed from Key Nanostructured Drug Players

Table 201. Nanostructured Drug Customers List

Table 202. Nanostructured Drug Distributors List

Table 203. Research Programs/Design for This Report

Table 204. Key Data Information from Secondary Sources

Table 205. Key Data Information from Primary Sources

List of Figures

Figure 1. Nanostructured Drug Product Picture

Figure 2. Global Nanostructured Drug Sales Market Share by Type in 2020 & 2026

Figure 3. Liposomes Product Picture

Figure 4. Polymeric Micelles Product Picture

Figure 5. Solid lipid Nanoparticles Product Picture

Figure 6. Microemulsion and Nanoemulsion Product Picture

Figure 7. Nanosuspension Product Picture

Figure 8. Global Nanostructured Drug Sales Market Share by Application in 2020 & 2026

Figure 9. Cancer and Tumors

Figure 10. Autoimmune Disorders

Figure 11. Nanostructured Drug Report Years Considered

Figure 12. Global Nanostructured Drug Market Size 2015-2026 (US$ Million)

Figure 13. Global Nanostructured Drug Sales 2015-2026 (K MT)

Figure 14. Global Nanostructured Drug Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Nanostructured Drug Sales Market Share by Region (2015-2020)

Figure 16. Global Nanostructured Drug Sales Market Share by Region in 2019

Figure 17. Global Nanostructured Drug Revenue Market Share by Region (2015-2020)

Figure 18. Global Nanostructured Drug Revenue Market Share by Region in 2019

Figure 19. Global Nanostructured Drug Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Nanostructured Drug Revenue in 2019

Figure 21. Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Nanostructured Drug Sales Market Share by Type (2015-2020)

Figure 23. Global Nanostructured Drug Sales Market Share by Type in 2019

Figure 24. Global Nanostructured Drug Revenue Market Share by Type (2015-2020)

Figure 25. Global Nanostructured Drug Revenue Market Share by Type in 2019

Figure 26. Global Nanostructured Drug Market Share by Price Range (2015-2020)

Figure 27. Global Nanostructured Drug Sales Market Share by Application (2015-2020)

Figure 28. Global Nanostructured Drug Sales Market Share by Application in 2019

Figure 29. Global Nanostructured Drug Revenue Market Share by Application (2015-2020)

Figure 30. Global Nanostructured Drug Revenue Market Share by Application in 2019

Figure 31. United States Nanostructured Drug Sales Growth Rate 2015-2026 (K MT)

Figure 32. United States Nanostructured Drug Revenue Growth Rate 2015-2026 (US$ Million)

Figure 33. United States Nanostructured Drug Market Share in Global Market 2015-2026

Figure 34. United States 5 and 10 Largest Nanostructured Drug Players Market Share by Revenue in Nanostructured Drug in 2019

Figure 35. United States Nanostructured Drug Revenue Share by Type (2015-2020)

Figure 36. United States Nanostructured Drug Revenue Growth Rate by Type in 2015 & 2019

Figure 37. United States Nanostructured Drug Revenue Share by Application (2015-2020)

Figure 38. United States Nanostructured Drug Revenue Growth Rate by Application in 2015 & 2019

Figure 39. North America Nanostructured Drug Sales Growth Rate 2015-2020 (K MT)

Figure 40. North America Nanostructured Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 41. North America Nanostructured Drug Sales Market Share by Country in 2019

Figure 42. North America Nanostructured Drug Revenue Market Share by Country in 2019

Figure 43. U.S. Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 44. U.S. Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Canada Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 46. Canada Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. Europe Nanostructured Drug Sales Growth Rate 2015-2020 (K MT)

Figure 48. Europe Nanostructured Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 49. Europe Nanostructured Drug Sales Market Share by Country in 2019

Figure 50. Europe Nanostructured Drug Revenue Market Share by Country in 2019

Figure 51. Germany Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 52. Germany Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. France Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 54. France Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. U.K. Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 56. U.K. Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Italy Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 58. Italy Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Russia Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 60. Russia Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Asia Pacific Nanostructured Drug Sales Growth Rate 2015-2020 (K MT)

Figure 62. Asia Pacific Nanostructured Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 63. Asia Pacific Nanostructured Drug Sales Market Share by Region in 2019

Figure 64. Asia Pacific Nanostructured Drug Revenue Market Share by Region in 2019

Figure 65. China Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 66. China Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Japan Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 68. Japan Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. South Korea Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 70. South Korea Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. India Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 72. India Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Australia Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 74. Australia Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Taiwan Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 76. Taiwan Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Indonesia Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 78. Indonesia Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Thailand Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 80. Thailand Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Malaysia Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 82. Malaysia Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Philippines Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 84. Philippines Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Vietnam Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 86. Vietnam Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Latin America Nanostructured Drug Sales Growth Rate 2015-2020 (K MT)

Figure 88. Latin America Nanostructured Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 89. Latin America Nanostructured Drug Sales Market Share by Country in 2019

Figure 90. Latin America Nanostructured Drug Revenue Market Share by Country in 2019

Figure 91. Mexico Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 92. Mexico Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Brazil Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 94. Brazil Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Argentina Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 96. Argentina Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Middle East and Africa Nanostructured Drug Sales Growth Rate 2015-2020 (K MT)

Figure 98. Middle East and Africa Nanostructured Drug Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Nanostructured Drug Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Nanostructured Drug Revenue Market Share by Country in 2019

Figure 101. Turkey Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 102. Turkey Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 104. Saudi Arabia Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Nanostructured Drug Sales Growth Rate (2015-2020) (K MT)

Figure 106. U.A.E Nanostructured Drug Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Porter's Five Forces Analysis

Figure 108. Nanostructured Drug Value Chain

Figure 109. Channels of Distribution

Figure 110. Distributors Profiles

Figure 111. Bottom-up and Top-down Approaches for This Report

Figure 112. Data Triangulation

Figure 113. Key Executives Interviewed

Merck

Pfizer

Novartis

Abbott

GlaxoSmithKline

Roche

Sanofi

Eli Lilly

Astrazeneca

Johnson & Johnson

Celgene

Novavax

Stryker

Gilead Sciences

OSI Pharmaceuticals

Kadmon Pharmaceuticals

Samyang Biopharm

Mitsubishi Pharma

Kaken Pharmaceutical

Selecta Biosciences

Par Pharmaceutical

Cerulean Pharma

Navidea Biopharmaceuticals

Lummy

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2964

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase